Wharton | Mr. LatAm Indian Trader
GMAT 720, GPA 3.5
HEC Paris | Mr. Indian Entrepreneur
GMAT 690, GPA 2.1
Darden | Mr. Education Consulting
GRE 326, GPA 3.58
Wharton | Mr. MBB to PE
GMAT 740, GPA 3.98
Stanford GSB | Mr. Unrealistic Ambitions
GMAT 710, GPA 2.0
Darden | Mr. Stock Up
GMAT 700, GPA 3.3
Harvard | Mr. MBB Aspirant
GMAT 780, GPA 3.7
Harvard | Ms. Finance
GMAT 760, GPA 3.48
Harvard | Mr. Soldier Boy
GMAT 720, GPA 3.72
UCLA Anderson | Mr. Worldwide
GMAT 730, GPA 3.1
Stanford GSB | Mr. Equal Opportunity
GMAT 760, GPA 4.0
Chicago Booth | Mr. Community Uplift
GMAT 780, GPA 2.6
Cornell Johnson | Mr. Angel Investor
GMAT 700, GPA 3.20
Rice Jones | Mr. ToastMasters Treasurer
GMAT 730, GPA 3.7
Kellogg | Mr. MBB Private Equity
GMAT TBD (target 720+), GPA 4.0
Said Business School | Ms. Creative Planner
GMAT 690, GPA 3.81 / 5.0
Stanford GSB | Mr. Wedding Music Business
GMAT 710, GPA 3.7
Harvard | Mr. Big 4 Auditor
GMAT 740, GPA 3.55
Harvard | Mr. Software PE
GMAT 760, GPA 3.45
Harvard | Mr. First Gen Consultant
GMAT 710, GPA 4.0 (First Class Honours)
Stanford GSB | Mr. Classic Candidate
GMAT 760, GPA 3.9
Stanford GSB | Mr. MBB/FinTech
GMAT 760, GPA 3.7
Stanford GSB | Mr. Break Into Buy-Side
GMAT 780, GPA 3.6
Harvard | Mr. Perseverance
GMAT 730, GPA 3.7
Stanford GSB | Mr. Politics Abroad
GRE 332, GPA 4.2/4.3
MIT Sloan | Mr. Canadian Banker
GMAT 720, GPA 3.7
Harvard | Ms. Fintech To Tech
GMAT 740, GPA 3.54


Mr. Armenian Geneticist

About Me:

I am currently a Computational Biologist at a hot Silicon Valley biotech, just recently IPO’d. Originally from Armenia, came to the US to study at MIT and then got a Master of Engineering degree there as well.


Undergrad School: MIT

Undergrad Major: CS and Biology

GPA: 3.7

GRE: 331

Age: 28,  Ethnicity: White

Other Degree/Certification: Master's

School Name: MIT

Extracurriculars: Secretary, MIT Armenian Society, Secretary, MIT Computer Science Honors Society

Work History:

Title: Computational Biologist

Industry: Healthcare

Company: Start-Up

Length of Employment: 2 yrs

Big Life Wins:

The only Computational Biologist in the company without a PhD (in an industry where R&D roles are extremely skewed towards PhD holders). Received a promotion within 18 months, for working on important projects that led to our IPO.

Post MBA Goal:

After MBA, I plan to stay in the biotech industry and hopefully launch a healthcare start up, focused on cancer diagnostics and treatment (personal connection to the disease). Feel I already have an extensive technological background, but want to learn the business side of things during the MBA studies.


Target School: Harvard

Status: Open

Considering: Stanford GSB


The Experts Rate The Odds At: 35%

  • The MBA Exchange | Odds Assessment: 40%

    This is JP from The MBA Exchange. I am a graduate of HBS and have guided many applicants to success over the last ten years, who share a background similar to yours. There are both opportunities and challenges in your profile if you’re targeting HBS, GSB and other top US programs. On the positive side, you have very clear expertise to share with classmates. It’s evident that you’d be a valuable addition to the classroom, especially in terms of healthcare cases. Furthermore, Boston is a hub for healthcare and HBS is very involved. You could easily connect with alumni and find career opportunities. You degrees from MIT will also be respected by the Admissions Committee. The main …

    6 months ago Read the full review
  • mbaMission | Odds Assessment: 30%

    Hi Mr. Armenian Geneticist, Julie-Anne Heafey here from mbaMission. I don’t totally agree with others’ views about your age – when I was at HBS, I had multiple friends who were in that age range. The average age at matriculation tends to be around 27 so you’d be a bit older than that, but that’s an average, not a ceiling and you’re still within the window to me. I do wonder a little bit about how your age lines up with your 2 years of stated experience and whether there’s a gap or not. Your work experience is actually on the low side for HBS males. I wouldn’t say it’s a dealbreaker (they care about impact more) but it’s something to look …

    6 months ago Read the full review

The Community Currently Rates The Odds At: 32%

  • 35% | 4 weeks ago

  • 30% | 6 months ago

Rate The Odds of Acceptance